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Abstract
Background: Contact tracing of tuberculosis (TB) patients is rarely performed in low-income countries. Our
objective was to assess the outcome of and compliance with directly observed treatment (DOTS) of TB patients
over a 3 year period in rural Lao PDR.
Methods: We performed a retrospective cohort study in which we enrolled TB patients who started DOTS
treatment at Attapeu Provincial Hospital. We traced, through hospital records, all patients in their residential village.
We conducted a standardized questionnaire with all TB patients and performed physical and anthropometric
examinations as well as evaluations of compliance through counting of treatment pills at home and at the health
facilities.
Results: Of 172 enrolled TB patients (sex ratio female/male: 0.52, mean age: 46.9 years ± 16.9), 26 (15.1%) died.
These had a lower weight at the start (34.6 vs. 40.8 kg, p < 0.001) and were less compliant (91.6% vs. 19.2%, p <
0.001) than survivors. Low compliance was associated with poor accessibility to health care (p = 0.01) and
symptomatic improvement (p = 0.02). Survivors had persistently poor health status. They were underweight
(54.7%), and still had clinical symptoms (53.5%), including dyspnoea (28.8%) and haemoptysis (9.5%).
Conclusion: Our study suggests a lower rate of survival than expected from official statistics. Additionally, it
showed that follow-up of TB patients is feasible although the patients lived in very remote area of Laos. Follow-up
should be strengthened as it can improve patient compliance, and allow contact tracing, detection of new cases
and collection of accurate treatment outcome information.
Background
Laos is a low income country with a per capita income
of USD 500 [1]; 39% of the population is classified as
poor. Mortality due to tuberculosis (TB) is estimated at
24 per 100,000 population, including HIV-co-infected
patients [2]. Lao People’s Democratic Republic (Lao
PDR, Laos) remains a HIV/AIDS low prevalence country
with an estimated 0.08% HIV sero-prevalence among the
adult population [3]. In Laos, TB annual incidence and
prevalence are estimated at 152 and 292 per 100,000,
respectively [4]. The TB detection rate has increased
from 57% in 2004 to 77% in 2006 [5].
Before 1995, tuberculosis treatment in Lao provincial
hospitals was either non-existent or highly irregular
[2,4]. In 1995-1996, the National Tuberculosis Program
(NTP) started a stepwise introduction of directly
observed treatment short-course (DOTS) with diagnosis
(microscopic for acid-fast bacilli [AFB]) and treatment
at the district level. Chest X-rays are not done routinely
[6] and impossible in many places. Free treatment is
offered to all smear-positive and to smear-negative
patients suspected with severe TB disease. The TB treat-
ment consists of an initial two months of four-drug
DOTS at the provincial hospital level (hospital-based,
HOSP), with financial support for subsistence during
hospitalization; followed by six months of two-drug
home-based (HOME) DOTS, with monthly visits to the
district hospital.
No financial compensation for loss of income or
transportation costs exists for TB patients at the district
level. They are enrolled and registered in DOTS at dis-
trict hospitals, where after initial hospital-based treat-
ment, patients receive drugs monthly. Non-compliant
patients are normally further visited by a district mobile
team, however, today, these visits are rarely conducted
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sibility to budget and transportation constraints.
As a result, little information is available on the TB
treatment outcome in Laos. The goal of this study was
to specifically assess the physical status, treatment out-
come and risk factors for non-compliance of TB patients
enrolled in DOTS in a chosen remote area in southern
Laos. We traced and examined patients enrolled in
DOTS treatment between 2002 and 2004 in the pro-
vince of Attapeu.
Methods
We performed a retrospective cohort study of TB
patients in Attapeu Province South of Laos from Febru-
ary to June 2005.
Study area
The study was performed in the rural province of Atta-
peu, located on the southern border with Vietnam and
Cambodia. Attapeu province has 108,000 inhabitants (10
inhabitants per km
2) scattered in 5 districts and 280 vil-
lages. The population is predominantly poor, illiterate
and belongs to ethnic minority groups. Mean monthly
household income is estimated to be 29 USD [1], and
access to health care is generally limited. In the Attapeu
provincial hospital, TB is the third most frequent cause
for outpatient attendance (247 of 8281 in 2004) and the
fifth most frequent cause of hospitalization (54 of 1632
in 2004). HIV prevalence in incident TB cases is 2% in
Laos [3].
Hospital records, patients definition and follow-up
We reviewed the records of all patients hospitalized
from January 2002 to December 2004 and identified all
TB patients. Tuberculosis was defined as either positive
AFB (3 sputum sample examination at Attapeu Hospital
and grading according to NTP criteria) or sputum nega-
tive with a suggestive chest x-ray result and a positive
result of the clinical algorithm provided by the NTP [7].
From the records, we collected information on hospi-
talizations including symptoms, weight, treatments,
length of stay, bacteriology, smear positivity and grading
according to the NTP [7].
All patients were traced in their residential villages.
On site, we interviewed the patient with a questionnaire
which was tested on comprehensiveness and subse-
quently improved questions. We obtained the following
information: current symptoms, chemotherapy, quality
of the relationship with the health facility’s medical staff,
attitudes regarding treatment and compliance, and
knowledge about TB. Subsequently, we performed a
general physical examination.
Patients were weighed lightly clothed using an electro-
nic SECA scale for adults (precision ± 100 g). Patients’
height was measured with a 0.1 cm precision using woo-
den measuring boards and a measuring tape. The
patient’s body mass index was calculated (BMI: weight/
height
2). Adults were considered underweight if BMI
was ≤ 18.5 and severely underweight if the BMI was <
16 [8]. We recorded body weight before treatment, dur-
ing treatment and during home visits for patients with
initially available data.
Definition
We used definitions of the NTP for compliance and
treatment achievement (completeness). A patient was
defined as compliant if, at the time of the survey, the
patient had taken at least 90% of the prescribed number
of tablets days [7]. On the other hand, non-compliant
patients (as determined by the pill counts of the NTP,
cross-checked with the district hospital data) were con-
sidered defaulters. A TB treatment was regarded as
c o m p l e t e di ft h ep a t i e n tf i n i s h e da tl e a s t9 5 %o fh i s
treatment days according to his treatment category [7].
Clinical outcomes
Survival rate was the primary outcome. Compliance with
treatment, and clinical outcome including nutritional
status and symptoms were the secondary endpoints.
Laboratory and field procedures
All patients were initially checked for AFB in their spu-
tum by the hospital. Assessing the sputum during fol-
l o w - u pw a sd o n eb yr e f e r r i n gt h ep a t i e n t st ot h e
provincial hospital for the scheduled 2-5 monthly spu-
tum checks by the NTP. NTP, with the help of Service
Fraternel d’Entraide, a non-governmental organisation,
was responsible for the training and regular quality
assessments of the laboratory.
A parallel survey was performed at the same time to
detect active TB cases and to conduct contact tracing in
the patients’ villages. Of the 84 villages with TB patients,
10 villages were randomly selected, and all inhabitants
with a chronic cough of more than 3 weeks (and/or hae-
moptysis) were screened using a questionnaire approach
[9]. We collected two sputum samples from patients
with chronic cough, one immediately and one the fol-
lowing morning, according to standard procedures of
the NTP [7]. Samples were collected each day and sent
to the district hospital where a Ziehl-Neelsen stained
slide was examined for the presence of acid-fast bacilli.
In addition, a sputum smear was directly examined for
the presence of Paragonimus eggs using a light micro-
scope [10]. Positive patients were referred to the provin-
cial hospital for treatment. We felt that the detection of
paragonimiasis (often clinically misdiagnosed as TB) was
justified as there has been some evidence of it in Laos
[10].
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Data was entered in Epidata freeware (http://www.epi-
data.dk, Odense, Denmark) and cross-checked against
original data sheets. Data analysis was carried out with
Stata, version 8 (Stata Corporation, College Station, TX,
USA). We used Fisher’s exact test to assess associations
between categorical variables, student’st - t e s tf o rt w o
normally-distributed continuous variables, log rank test
to compare the durations of treatment and hospitalisa-
tion between compliant and non compliant, and
between survivors and non survivors and t-test for two-
sample mean-comparison of paired data for the patients
weight evolution. We assessed the compliance factors.
First, we analyzed the factors affecting the compliance
in an univariate analysis. Second, all factors with p
values ≤ 0.2 were then fitted into a multivariable logistic
regression model. We considered p < 0.05 as significant.
All participants gave informed witnessed verbal con-
sent. The study was approved by the Ministry of
Health’s Ethical Council of Medical Sciences for Health
Research and the provincial health authorities. The
study was performed in accordance with the Declaration
of Helsinki.
Results
A total of 172 TB patients were registered at the Atta-
peu Provincial hospital between 2002 and 2004. They
came from 80 villages and 5 districts of the province
(Samakhisay 42%, Saysetha 22%, Sanamsay 28%, Sansay
5%, Phouvong 3%). The number of patients decreased
with increasing distance to Attapeu city. They started
their treatment in 2002 (n = 53), 2003 (n = 51), and
2004 (n = 68).
Of the 172 TB patients, 159 patients had pulmonary
TB (92.4%, Figure 1). All patients were visited at home,
and the mean duration of treatment at the time of the
home visit was 6 months. Table 1 and Table 2 present
the main characteristics of the patients when hospita-
lized and during the home visits, respectively. All
patients were rice farmers, living in 80 different remote
villages of the province, where transportation means
were scarce.
Twenty-six patients (15.1%) died (mean time to death
after diagnosis: 256 days ± 304 days). Twelve patients
died during hospitalization (mean time to death: 31.8
days ± 20.2 days) and 14 patients died at home (mean
time to death: 81.4 days ± 69.0 days). The death rates
were similar over the 3 years period (18.8%, 15.7%,
11.8%, respectively, p = 0.5). Patients who died tended
to be older than the survivors, although this difference
was not statistically significant (p = 0.1). Non-survivors
had lower weight on admission (p < 0.001), suffered
more severe symptoms, and were less compliant than
survivors (p < 0.001).
At the time of our study, 80 of 146 patients (54.8%)
were underweight and 30 (20.5%) were severely under-
weight. Patients with extrap u l m o n a r yT Bh a dab e t t e r
nutritional status than patients with pulmonary TB (p =
0.01). The evolution of the patients’ weight under treat-
ment is shown in Table 3. The body weight on hospital
admission was excessively low (40 kg or less). The
weight gain was more sizeable during hospitalization (+
9.5% per month) than during home treatment (p <
0.001).
We performed, at the time of DOTS enrolment, 166
(96.5%) sputum tests. At months 2, 5, and 8 after enrol-
ment, the rates of sputum testing was 73.9% (n = 108),
63.0% (n = 92) and 55.4% (n = 81) respectively. After 2
months, 5 of 142 (3.5%) sputum follow-up examinations
remained positive. Three of these were negative at 5
months, one not checked after 5 months was reported
negative at 8 months of treatment, and data of one
patient was not available. No sputum was reported posi-
tive after 5 and 8 months treatment (Figure 2).
Most TB patients (116 of 146, 79.5%) were heavy smo-
kers, most of them since childhood, with strikingly high
rates in males (88 of 96, 91.7%) even compared to
females (28 of 50, 56.0%; p < 0.001). One-third of the
patients reported their health had not improved during
treatment and reported persistent symptoms as well as
signs of TB during home visits (Table 2).
One patient appeared severely ill with fever, cough
and general weakness when visited at home. Also, three
patients had permanent dyspnoea with chest retraction,
and among the 14 patients with haemoptysis, 8 had
completed their treatment. We found more clinical
signs in non-compliant patients (42.8% vs. 28.1, p =
0.04).
64 of 144 (44.4%) patients complained of difficulties
with observance of the drug regime. These patients were
less compliant than those who did not complain (p <
0.01). Compliant patients had a 5.2 chance of survival
compared to non compliant (RR: 5.2; 95% CI: 3.2-8.5).
After multivariate analysis, the main factors of non-
compliance were the distance to the hospital and the
feeling of general health improvement (Table 4).
In the sub-study that was performed in 10 villages,
sputum analysis from patients, close contacts and people
with chronic cough were performed. Among 180 per-
sons reporting chronic cough, we detected 5 (2.8%)
adults with a TB positive sputum examination. Seven
(3.9%) had Paragonimus sp. eggs in their sputum.
Discussion
Our study assessed the outcome over a 3 years period of
172 registered TB patients who started DOTS treatment
at the provincial hospital in Attapeu. Visits performed
during the home-treatment phase allowed us to detect
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large proportion of the patients (53.5%) that were still
suffering from pulmonary symptoms. Nearly 10% of
them were having haemoptysis, despite 8 of 14 (57.1%)
having completed the treatment. Furthermore, village
visits in 10 of the 80 villages allowed the diagnosis of 5
new TB and 7 new paragonimiasis cases which lived
close to TB patients. Our study documents the essential
role of home visits in improving a TB program aimed
for remote areas.
At this time, home visits are rarely performed in prac-
tice and many efforts describing patient outcomes are
Figure 1 Flow chart of tuberculosis patients through the follow up in southern Lao PDR. * Misclassified in hospital statistics
Table 1 Characteristics of 172 TB patients prior to treatment in Attapeu province hospital, Lao PDR
Total Pulmonary TB Extra Pulmonary TB
n = 172 n = 159 n = 13 p
Female 59 (34.3) 52 (32.7) 7 (53.8) 0.12
Sex ratio (F/M) 0.52 0.49 1.17 0.12
Children < 15 years (%) 5 (2.9) 4 (2.5) 1 (0.7) 0.28
Age (years) 46.9 (16.9) 47.5 (1.3) 39.6 (4.2) <0.001
Weight (kg, n = 169) 39.9 (1.4) 39.7 (0.7) 43.7 (3.1) <0.001
BMI (n = 146) 18.2 (17.7-18.6) 18.1 (17.6-18.5) 20.1 (18.7-21.6) 0.01
Outside of the main city 93 (54.0%) 84 (52.8%) 7 (61.2%) 0.94
Median distance to Health Centre (km) 15.0 (0-87) - -
Median time to Health Centre (mn) 60.0 (10-600) - -
Sputum positive (n = 166) 154
(92.7%)
152/158
(96.2%)
2/8
(25.0%)
<0.001
Treatment
2 srhz/6 he 2 (1%) 1 (0.5%) 1 (7.6%) 0.44
2 rhze/6 he 143 (83.1%) 134 (84.2%) 9 (64.2%) <0.001
Others 27 (15.7%) 24 (15.0%) 3 (23.0%) 0.44
Mean (standard deviation) and number (rate) for continuous and discrete characteristics, respectively.
s = streptomycine, r = rifampicine, h = isoniazide, z = pyrazinamide, e = ethambuthol
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shown that, in remote areas, home visits can contribute
substantially to achieve the WHO-recommended target
of 85% cure-rate by timely identification of defaulters
and close-contact tracing [8]. The effectiveness of home
visits remains high even when patients are seen by non
professional health-workers. Home visits also improve
case detection rates by examination of close contacts.
Children in close contact with patients are at particu-
larly high risk of TB [12]. In Northern Laos, the risk of
latent TB infection in children was increased 6-fold in
close contacts [13]. Active case-detection among house-
hold contacts yields nine times more TB cases than pas-
sive case detection, and is an opportunity for reducing
TB morbidity and mortality [14].
The proportion of sputum controls at 2, 5, 8 months
was low. Health-workers who deliver the drugs monthly
should also carefully check whether scheduled sputum
examinations have been completed. Our follow-up study
further documents the generally acknowledged advan-
tages of home visits and quantifies the sizable amount
of treatment defaulters and newly diagnosed TB patients
among contacts. We argue that in low income countries
such as Laos, active monito r i n go fD O T ST Bp a t i e n t s-
not just routine drug delivery - is particularly essential
as initial efforts to diagnose and treat patients with TB
would be otherwise wasted.
Our study shows that reaching patients in most
remote villages is feasible even with limited resources.
In Laos, this is possible because the active system of vil-
lage leaders in place allows for tracing people. This fea-
ture of Laos’ administration, culture and society should
be used and expanded to increase TB patient follow-up
locally; nevertheless, it should be reminded that in other
poor rural countries, this type of social organisation may
not be present.
The short time to death after diagnosis and the com-
promised nutritional status suggest that patients only
sought care very late in the course of their disease. This
reflects observations in neighbouring rural China bur-
dened with similar patient and physician’s delays. This
Table 2 TB patient outcome during home visit in
Attapeu, Lao PDR
Survivors Dead
n = 146 n = 26 p
Sex ratio (F/M) 50/96 (0.52) 9/17 (0.53) 0.97
Age (years) (95% CI) 46.2 (43.5-
48.9)
51.3 (43.6-
58.9)
0.1
Weight (Kg) on admission at
hospital
40.8 (0.6) 34.6 (11.9) <0.001
BMI (95% CI) 18.2 (17.7-
18.6)
-
Patients with BMI <18.5 (%) 80 (54.8) -
Completed treatment (%) 81 (55.4) Not known
Non-compliant patients (%) 28 (19.2) 22 (91.6%) <0.001
Duration of treatment
on the day of visit (days)
187.3 (3.2) 91.2 (19.3) <0.001
Duration of hospitalization (days) 61.0 (7.8) 47.5 (3.9) <0.001
Average missing days of treatment
(days)
28.8 (4.2) 61.7(15.2) <0.001
Physical examination
Tiredness (%) 52 (35.6) -
Chronic cough (%) 68 (53.5) -
Haemoptysis (%) 14 (9.5) -
Dyspnoea (%) 38 (28.8) -
Mean (standard deviation) unless otherwise stated, CI confidence interval, and
number and percent for continuous and discrete characteristics, respectively.
Table 3 Weight evolution of 72 patients under treatment
with an 8 months follow-up
Weight (kg) 95% CI p
Before treatment 40.0 38.1- 41.8
After two months of treatment 43.7 41.7- 45.7 <0.001
After 8 months of treatment 44.6
a 42.7 - 46.5 <0.001
Mean and 95% confidence interval
a Patients were selected on the basis of having both 2 and 8 month data
which probably means that they are not representative of the whole cohort
Figure 2 Sputum examination during the follow-up of
tuberculosis patients in Attapeu, Lao PDR. Not all patients
underwent a sputum examination which possibly underestimated
the number of positive sputum over time.
Table 4 Reasons reported by patients for non-compliance
with TB treatment, Attapeu, Lao PDR (n = 146)
RR 95% CI p
Long distance to health centre 8.7 1.5 - 48.5 < 0.01
Physical Improvement* 2.7 1.1- 6.6 0.02
Lack of financial resources 2.1 0.3-13.5 0.4
Lack of transportation 1.9 0.3-10.7 0.4
Need to work 1.6 0.5- 5.3 0.4
Family disorders 0.3 0.0 - 1.5 0.1
RR: relative risk, CI confidence interval
Multivariate analysis using Cox proportional hazard model
* Patients felt that they had decreased pulmonary symptoms and felt fitter
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ance of patients in remote areas, which are unfortu-
nately nearly two times higher than the national
statistics [2]. Our patients were chosen out of the hospi-
tal records and might have been the more serious cases,
causing in turn an overestimation of the low health sta-
tus of our sample. However, in Laos all TB patients are
hospitalised for the initial phase of DOTS, regardless
their physical status.
Our study demonstrates the relationship between
compliance during DOTS, the difficult geographical
access to health services, and the patients’ self percep-
tion of improvement. In rural Laos, transportation is
expensive: a patient living 40 km from the health centre
has a 4 USD round-trip to obtain his treatment. This is
a substantial cost given a per capita income of 500
USD/year. Decentralization of DOTS and active follow-
up at the health centre or village will increase access,
and efforts to realize this improvement are currently
underway. Other compliance factors which are known
from other settings such as the bitterness of the drugs,
the relationship and communication barriers with
health-workers [15], were not of importance in our set-
ting. Interestingly, compliance to DOTS was similar dur-
ing hospitalization and home treatment periods. Hence,
factors other than difficult geographical access must
exist.
We conducted our study with limited resources, our
results relying largely on interviews and basic physical
examinations. Systematic sputum examination was per-
f o r m e do n l yi nas u b - s a m p l eo fv i l l a g e s ,a n de t i o l o g yo f
persistent symptoms could not be followed-up in detail;
i.e. the role of drug resistance, treatment failure,
advanced or complicated TB, associated lung injuries
due to heavy smoking, or paragonimiasis, remain
unknown. Paragonimiasis is endemic in Laos and is fre-
quently overlooked [10,16]. The severity of disease at
treatment onset could not be judged on records alone.
Finally, smoking of locally grown tobacco is very com-
mon in rural Laos, even in children or pregnant women.
Smoking during childhood is associated with a higher
risk of TB, and facilitates pulmonary disease transmis-
sion [17,18]. However, in this study, we could not quan-
tify the contribution of smoking to pulmonary disease;
thus the call remains for future investigations to address
this issue from the perspective of TB control, and help
quantify and raise awareness about anti-smoking cam-
paigns in rural Laos.
Conclusion
Home visits of TB patients and contact tracing are feasi-
ble in remote rural Laos even with limited resources.
The level of survival of TB patients after DOTS is prob-
ably lower than can be expected from the rate of
treatment. Home visits could probably help improve
physical follow-up of patients and the rate of sputum
follow-up. The insight they provide into the effective-
ness of the NTP is essential. Home visits are a step
toward improved access to care services at the periph-
eral level. Further quantification of increased effective-
ness of TB programs in resource poor countries through
home visit and contact tracing may lead to a wider use
of this practice.
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